- Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
-
Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH
- KMID: 1781820
- J Korean Med Sci.
- 2006 Apr;21(2):188-192.
- doi: 10.3346/jkms.2006.21.2.188
This study was undertaken to evaluate the in vitro activities of arbekacin-based combination regimens against vancomycin hetero-intermediate Staphylococcus aureus (hetero-VISA). Combinations of arbekacin with vancomycin, rifampin, ampicillin-sulbactam, teicoplanin, or quinipristin-dalfopristin... -
- CITED
-
- Close
- SHARE
-
- Close
- Quinupristin/Dalfopristin-induced Sweet's Syndrome
-
Choi HS, Kim HJ, Lee TH, Lee SH, Lee TW, Ihm CG, Kim MJ
- KMID: 759659
- Korean J Intern Med.
- 2003 Sep;18(3):187-190.
Quinupristin/Dalfopristin is a new combination of streptogramin antibiotics designed specifically to treat clinically significant infections due to Vancomycin-resistant Enterococcus Faecium. Sweet's syndrome is characterized by painful skin plaques, which is... -
- CITED
-
- Close
- SHARE
-
- Close
